Studies in chronic kidney disease (CKD) patients demonstrated that serum βTP is an adequate marker of glomerular filtration rate (GFR) impairment with a diagnostic accuracy similar to those of serum creatinine, cystatin C (Cys) and β2-microglobulin (β2M) [11–15]. The gene discussed is CST3; the disease is chronic kidney disease.